Comment
. 2002 Jul;61(7):667; author reply 667.
doi: 10.1136/ard.61.7.667.
Soluble TNF receptor treatment does not affect raised TGF beta levels in RA
- PMID: 12079925
- PMCID: PMC1754162
- DOI: 10.1136/ard.61.7.667
Item in Clipboard
Comment
Soluble TNF receptor treatment does not affect raised TGF beta levels in RA
Ann Rheum Dis.
2002 Jul.
No abstract available
Comment on
-
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor beta levels in rheumatoid arthritis.Ann Rheum Dis. 2002 Mar;61(3):254-6. doi: 10.1136/ard.61.3.254. Ann Rheum Dis. 2002. PMID: 11830433 Free PMC article.
Similar articles
-
Soluble tumour necrosis factor receptor treatment does not affect raised transforming growth factor beta levels in rheumatoid arthritis.Ann Rheum Dis. 2002 Mar;61(3):254-6. doi: 10.1136/ard.61.3.254. Ann Rheum Dis. 2002. PMID: 11830433 Free PMC article.
-
Etanercept improves rheumatoid arthritis partially responsive to methotrexate.Clin Exp Rheumatol. 2001 Nov-Dec;19(6):626-7. Clin Exp Rheumatol. 2001. PMID: 11791631 No abstract available.
-
Etanercept increases adiponectin level in woman with rheumatoid arthritis.Clin Rheumatol. 2008 Oct;27(10):1337-8. doi: 10.1007/s10067-008-0957-2. Epub 2008 Jul 24. Clin Rheumatol. 2008. PMID: 18651101 No abstract available.
-
[Etanercept: recombinant human soluble tumor necrosis factor receptor fusion protein].Nihon Rinsho. 2007 Jul;65(7):1211-7. Nihon Rinsho. 2007. PMID: 17642234 Review. Japanese.
-
Pharmacogenetics of etanercept in rheumatoid arthritis.Pharmacogenomics. 2008 Aug;9(8):1011-5. doi: 10.2217/14622416.9.8.1011. Pharmacogenomics. 2008. PMID: 18681777 Free PMC article. Review.
Cited by
-
C-ANCA positive systemic vasculitis in a patient with rheumatoid arthritis treated with infliximab.Clin Rheumatol. 2008 Feb;27(2):261-4. doi: 10.1007/s10067-007-0712-0. Epub 2007 Aug 22. Clin Rheumatol. 2008. PMID: 17712519 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
